Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

Wegovy can be prescribed to help with long-term weight loss, along with diet and exercise, in children ages 12 years and older with obesity. Ozempic is not prescribed off-label for this use.

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Amid new Canadian guidelines suggesting GLP-1 medication for obese kids and teens, dietitians say there are better ways ...